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T cell stimulation requires the input and integration of external signals. Signaling through
the T cell receptor (TCR) is known to induce formation of the membrane-tethered CBM
complex, comprising CARMA1, BCL10, and MALT1, which is required forTCR-mediated NF-
κB activation.TCR signaling has been shown to activate NOTCH proteins, transmembrane
receptors also implicated in NF-κB activation. However, the link between TCR-mediated
NOTCH signaling and early events leading to induction of NF-κB activity remains unclear.
In this report, we demonstrate a novel cytosolic function for NOTCH1 and show that
it is essential to CBM complex formation. Using a model of skin allograft rejection, we
show in vivo that NOTCH1 acts in the same functional pathway as PKCθ, a T cell-specific
kinase important for CBM assembly and classical NF-κB activation. We further demon-
strate in vitro NOTCH1 associates physically with PKCθ and CARMA1 in the cytosol.
Unexpectedly, when NOTCH1 expression was abrogated using RNAi approaches, inter-
actions between CARMA1, BCL10, and MALT1 were lost. This failure in CBM assembly
reduced inhibitor of kappa B alpha phosphorylation and diminished NF-κB–DNA binding.
Finally, using a luciferase gene reporter assay, we show the intracellular domain of NOTCH1
can initiate robust NF-κB activity in stimulatedT cells, even when NOTCH1 is excluded from
the nucleus through modifications that restrict it to the cytoplasm or hold it tethered to the
membrane. Collectively, these observations provide evidence that NOTCH1 may facilitate
early events during T cell activation by nucleating the CBM complex and initiating NF-κB
signaling.
Keywords: NOTCH1, CARMA1, PKCθ, NF-κB, non-canonical, cytosolic,T cell subject category: immunology, signal
transduction
INTRODUCTION
Antigen-specific signaling in T cells originates at the membrane via
the T cell receptor (TCR) and culminates in nuclear transcription
of genes that effect specific biological outcomes. This tightly regu-
lated process requires the oligomerization and physical association
of CARMA1, BCL10, and MALT1 into the macromolecular CBM
complex (1, 2). Successful assembly of the CBM structure requires
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the upstream actions of kinases such as PDK1 and GLK, which
facilitate phosphorylation of PKCθ, and CARMA1, which itself is
phosphorylated by PKCθ (3–7). Loss of any of the CBM compo-
nents stymies full T cell activation (1, 8–10). PKCθ-deficient T cells
are unable to form CBM signalosomes and show faulty activation
following stimulation through the TCR, including reduced CD25
expression, low levels of IL-2 production, and decreased prolifer-
ative potential (6). These defective responses are due in part to
insufficient activation of the NF-κB signaling cascade (11).
The NF-κB family of nuclear transcriptional regulators com-
prises five subunits, p50, p65, c-rel, RelA, and RelB. These subunits
co-assemble into homo- or heterodimers to direct unique and
specific transcriptional regulation when they bind to recognition
elements in the promoters of target genes (12). Two pathways of
NF-κB signaling have been described, each of which culminate
in distinct biological outcomes. Signaling through CD40–CD40L
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interactions in T cells can initiate the non-classical NF-κB cascade,
while the classical pathway is thought to be the primary mediator
of T cell activation down-stream of TCR engagement. This process
requires PKCθ phosphorylation, inhibitor of kappa B kinase (IKK)
activation, and phosphorylation of its target substrate, inhibitor of
kappa B alpha (IκBα), all of which serve to liberate NF-κB subunits
from their inactivating complex in the cytosol and initiate classical
NF-κB signaling (13, 14). Thus, through its direct action on the
CBM complex, PKCθ links proximal TCR signals with temporally
delayed biological outcomes mediated by transcription of NF-κB
target genes (6).
NOTCH proteins (NOTCH1–4) are evolutionarily conserved
transmembrane receptors critically important to an array of bio-
logical functions. Mammalian NOTCH binds ligands from one
of two families, designated as Delta-like ligand (Dl1, 3, 4) or
Jagged (Jag1, 2). In the immune system, NOTCH signaling is vital
for T cell development, activation, proliferation, and differenti-
ation into T helper subsets (15). NOTCH receptors undergo a
series of enzymatic cleavages, including a final activating cleavage
by gamma-secretase which liberates the intracellular, signaling-
competent form of NOTCH (NIC) from the cell membrane and
allows its translocation to the nucleus. This final cleavage event
can be prevented pharmacologically with inhibitors of gamma-
secretase (GSI). NOTCH1 signaling is required for peripheral T cell
activation and, like PKCθ-deficient T cells, T cells with impaired
NOTCH1 signaling show reduced CD25 expression, decreased
IL-2 production, and attenuated proliferation (16–18). We previ-
ously showed that nuclear NOTCH1 (N1IC) is required to sustain
T cell activation and proliferation by retaining NF-κB in the
nucleus at time points exceeding 12 h post-stimulation (19). More
recently, a novel, extra-nuclear role was attributed to N1IC. That
study showed 48 h after stimulation, in regulatory T cells, N1IC
uniquely redistributed to the cytosol and associated with cytoplas-
mic RICTOR to protect regulatory T cells from apoptosis following
cytokine withdrawal (20–22). However, a cytosolic function for
N1IC in regulating cellular events that occur within minutes to
hours after T cell activation has not been fully explored.
Therefore, we focused our inquiry on molecular interactions
that occur downstream of TCR engagement and their potential to
influence early NF-κB induction in activated T cells. Specifically,
we asked whether NOTCH1 might act as a cytosolic scaffold to
facilitate CBM assembly and NF-κB activation. Using microscopy
and biochemical approaches, we show that cytosolic N1IC associ-
ated physically with PKCθ and CARMA1 and nucleated the CBM
complex. Blocking NOTCH1 protein expression using shRNA
abrogated its association with PKCθ and CARMA1. Surprisingly,
in the absence of NOTCH1 expression, the ability of CBM mem-
bers to bind each other also was lost, suggesting cytosolic NOTCH1
may act as a scaffold protein to facilitate the docking and aggre-
gation of CBM components. Finally, using a luciferase reporter
assay and N1IC constructs with restricted localization, either to
the cytosol or to the plasma membrane, we demonstrated that
non-nuclear N1IC was capable of inducing robust NF-κB activity
in stimulated T cells. Altogether, these data support a novel model
suggesting N1IC has the potential to function in the cytoplasm to
amplify TCR signals and promote early T cell activation through
its physical association with members of the CBM complex.
MATERIALS AND METHODS
ANIMALS
All mouse protocols were approved by the Institutional Ani-
mal Care and Use Committee of the University of Massachu-
setts/Amherst. Offspring between the ages of 9 and 12 weeks
were used in experiments. PKCθnull mice were obtained from
Dan Littman (New York University, NY, USA). C57BL/6, p50null,
and NOTCH1 floxed mice were obtained from the Jackson
Laboratory (Bar Harbor, ME, USA). NOTCH1 conditional
floxed mice (N1KO) were generated by crossing NOTCH1fl/fl
(NOTCH1tm2Rko/GridJ) to Mx1-Cre± [B6.Cg-Tg(Mx1-cre)1Cgn/J]
from the Jackson Laboratory (Bar Harbor, ME, USA). To condi-
tionally delete NOTCH1 from splenocytes of skin allograft recip-
ients, poly(I)–poly(C) (Amersham Biosciences, Piscataway, NJ,
USA) was dissolved in phosphate buffered saline (PBS) and given
in vivo as previously described (23).
MURINE SKIN ALLOGRAFTING AND IN VIVO ADMINISTRATION OF GSI
Recipient mice (p50null, PKCθnull, N1KO, WT) were all on a
C57BL/6 background. Donor grafts from BALB/c or C57BL/6 mice
were prepared by removing the skin from the ventral side of the ear
and placing in cold PBS. Recipient mice were anesthetized using
isoflurane and administered 5 mg/kg of Ketofen® (Ketoprofen)
subcutaneously. Fur was shaved off the dorsal torso of recipients
and graft beds were prepared by removing skin from two adja-
cent sites. Donor skin was placed over the graft bed and excess
donor skin from the donor was trimmed away. The allograft was
secured using Vaseline® gauze and a Band Aid® which was fas-
tened using silk suture. On day 7, bandages were removed and
grafts were visually scored for signs of rejection using a scale of
1–10, with 1 being completely rejected. An allograft was consid-
ered fully rejected when it was>80% necrotic (24). Each recipient
mouse also received a syngeneic skin graft to control for the
integrity of the grafting technique. Some mice were fed GSI in
rodent chow (Tekland) formulated to deliver 5 mg/kg/day begin-
ning 2 weeks prior to skin allografting and continuing until grafts
were considered to be fully rejected.
PLASMIDS
The N1IC parental pcDNA3 expression plasmids were a kind gift
of A. Capobianco (25). Mutant constructs were generated by sub-
cloning into pEGFP vector-C1 (BD Biosciences) at the BglII and
SalI sites. The N1IC constructs containing either a nuclear export
signal (NES) or a nuclear localization signal (NLS) were previously
described (22): LALKLAGLDLEQKLISEEDL (NES sequence is in
bold and Myc epitope is underlined), PKKKRKVEQKLISEEDL
(NLS sequence is in bold, and Myc epitope is underlined). cDNAs
of N1IC–NES or N1IC–NLS were subcloned into BamHI and
SalI sites of pEGFP-C1 vector [BD Biosciences; Ref. (19)]. The
cDNA of NOTCH1∆E from pGD-∆E was subcloned into BglII
and SalI sites of pEGFP-C1 vector. N1IC in the pEGFP–N1IC–
NES construct, was replaced with cDNAs of N1IC mutants to be
fused to additional NES, and confirmed by sequencing and by
immunoblotting following overexpression in 293T cells. cDNA of
CARMA1 in pCR3 expression plasmid with vesicular stomatitis
virus (VSV) tag was previously described (26). We constructed
the pRRL U6 shRNA PGK puro SIN LTR-containing shRNA
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sequence against NOTCH1 using the VSV envelope glycoprotein
(G protein) expression plasmid (pHCMV-G) and the packaging
plasmid for HIV-1-based vectors (pCMV∆R8.2), which is used
in lentivirus particle production (kindly provided by S. A. Stew-
art, Washington University School of Medicine, St. Louis, MO,
USA). The reporter construct of NF-κBx3 Luc was purchased from
Clontech Laboratories, Inc. (Mountain View, CA, USA). To pro-
duce the NOTCH1∆E-PM construct, site-directed mutagenesis
of NOTCH1∆E was accomplished using the QuikChange muta-
genesis system (Stratagene, La Jolla, CA, USA) according to the
manufacturer’s protocol. The following primer set was used to
introduce point mutations within the cleavage site of Val1744 in
NOTCH1: Val to Gly 5′-C TTC GTG GGC TGC GGT GGT CTG
CTG TCC CGC AAG-3′, Val to Gly antisense 5′-CTT GCG GGA
CAG CAG ACC ACC GCA GCC CAC GAA G-3′. Substituted
codons are in bold. PCR conditions: 94°C for 30 s, 94°C for 30 s,
55°C for 1 min, and 68°C for 9 min (18 cycles), then followed by the
treatment with 1µl DpnI restriction enzyme at 37°C for 2 h. The
∆E point mutation construct generated by PCR was confirmed by
sequencing and by immunoblot following overexpression in 293T
cell line.
ANTIBODIES
Anti-p50 (sc-1190X), anti-c-Rel (sc-71X), anti-p65 (sc-372X),
anti-IκBα (sc-371), anti-NOTCH1 (sc-6014-R), anti-GFP (sc-
8334), anti-BCL10 (sc-9558 and sc5273), anti-CARMA1 (sc-
20458), anti-IKKα (sc-7606), anti-IKKγ (sc-8330), normal goat
IgG (sc-2043), and normal rabbit IgG (sc-2027) were purchased
from Santa Cruz Biotechnology (Santa Cruz, CA, USA); cleaved
N1 (#2421) and phospho-IκBα (#9241) antibodies were from
Cell Signaling Technology (Beverly, MA, USA). GAPDH antibody
(MAB374) was from Chemicon International, Inc. (Temecula,
CA, USA). Anti-human CD3ε (145-2C11) and anti-human CD28
were obtained from R&D Systems (Minneapolis, MN, USA). Anti-
CARMA1 (#3189) was obtained from ProSci, Inc. (Poway, CA,
USA). Cholera toxin (CTX) B subunit, FITC-labeled (C 1655),
monoclonal anti-VSV glycoprotein (V 5507), and anti-β-actin
were purchased from Sigma-Aldrich (St. Louis, MO, USA).
CELL CULTURE
Jurkat T cell lines were cultured in RPMI media containing 10%
fetal bovine serum (FBS, Invitrogen), 10µM β-mercaptoethanol,
penicillin/streptomycin, and gentamicin. Sixty millimeter dishes
were pre-coated with 20µg/ml of anti-mouse IgG at room temper-
ature for 2 h and then incubated with 5µg/ml, each, of anti-human
CD3ε and anti-human CD28 at 4°C, overnight. Jurkat T cells
(1.5× 107 cells per dish) were seeded into antibody-pre-coated
60 mm dishes for indicated time periods and harvested for the
experiments described below. Peripheral blood mononuclear cells
(PBMC) were prepared from buffy coats (LifeSource, Glenview,
IL, USA) obtained from healthy adult donors on Ficoll-PAQUE
gradient (GE Healthcare, Uppsala, Sweden). For primary human
T cell experiments, CD4+ T cells were purified from PBMC by
negative selection using LS columns (Miltenyi Biotech, Sunnyvale,
CA, USA). CD4+ T cells were≥95% pure. Cells were cultivated in
37°C incubator and 5% CO2 in RPMI 1640 medium supplemented
with 10% FBS (Hyclone, Thermo Fischer Scientific, Waltham, MA,
USA), penicillin–streptomycin, 2 mM glutamine, 1 mM pyruvate,
10 mM HEPES, and 0.1 mM non-essential amino acids. CD4+ T
cells were stimulated by anti-CD3ε and CD28-coated Dynabeads
(Invitrogen/Life Technologies, Grand Island, NY, USA), at a 1:1
(bead:cell) ratio.
IMMUNOLOGICAL SYNAPSE FORMATION – CD4+ T CELL-BEAD
CONJUGATION
Dynabeads (2× 105) were coated with anti-CD3ε and CD28 then
were combined with primary mouse CD4+ T lymphocytes (1:1
ratio) in 200µl of serum-free media for 5 min at room temper-
ature. The bead-T cell mixtures were then loaded onto a poly-l-
lysine-coated glass coverslips for 15–30 min at 37°C, rinsed briefly
in PBS, and immediately fixed.
IMMUNOFLUORESCENCE STAINING AND CONFOCAL MICROSCOPY
ANALYSIS
Samples were fixed 20 min in 3% paraformaldehyde (PFA) in PBS,
quenched with 50 mM NH4Cl/PBS, permeabilized for 1 min in
0.3% Triton X-100, and blocked with a solution of PSG [PBS,
0.01% saponin, 0.25% fish skin gelatin, and 0.1% NaN3 (all from
Sigma-Aldrich)]. The fixed cells were incubated for 1 h with the
primary antibodies against PKC-θ and NOTCH1 (Santa Cruz
Biotechnology), washed five times in PSG, and then incubated for
1 h with the fluorochrome-labeled rabbit or donkey-anti-species-
specific secondary antibodies (Jackson ImmunoResearch, West
Grove, PA, USA). The coverslips were then washed five times
in PSG, rinsed in ddH2O, and mounted with ProLong® Gold
Antifade reagent (Invitrogen/Life Technologies). Stained cells were
visualized with a Zeiss LSM 510 Meta Confocal Microscope,
using a 63× oil immersion objective. Thirty-five to 50 z-sections,
separated by 0.2µM, were acquired.
LIPID RAFT ISOLATION
Jurkat T cells (5× 107 cells) were stimulated as described and
lysed on ice for 20 min in 500µl of 1% Triton X-100 in MN buffer
(25 mM MES, 150 mM NaCl, pH 6.5) supplemented with protease
inhibitor cocktail (Sigma-Aldrich). The cell lysate was homog-
enized with a loose-fitting Dounce homogenizer (15 strokes)
and spun at 500× g for 7 min at 4°C. Post-nuclear supernatant
(400µl) was mixed with 400µl of 80% sucrose diluted with MN
buffer, then overlaid with 800µl of 36% sucrose and 400µl of 5%
sucrose. The gradients were spun for 24 h at 4°C at 220,000× g.
Nine fractions (220µl each) were collected from bottom to top.
All fractions were analyzed by dot blot with anti-CTX-conjugated
horse radish peroxidase (HRP) prior to immunoblotting with the
antibodies indicated in each figure.
CO-IMMUNOPRECIPITATION ASSAYS ANDWESTERN BLOTTING
293T cells were transfected with the plasmids indicated, using
FuGENE6® (Roche Diagnostics, Indianapolis, IN, USA). After
2 days, cells were lysed for 30 min at 4°C in 500µl of 1% NP-
40 lysis buffer (10 mM Tris-HCl pH 7.8, 0.5 mM EDTA, 250 mM
NaCl, and protease inhibitor cocktail). For Jurkat T cells, 1.5× 107
cells were incubated in 60 mm dishes pre-coated, as described, with
anti-human CD3ε and anti-human CD28 for the indicated time
points, then lysed in 500µl of 1% NP-40 lysis buffer. Supernatants
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were incubated with 10µl of normal serum and 100µl of protein
G-sepharose beads (Pharmacia, Stockholm, Sweden) at 4°C on a
rotator for pre-clearing. After centrifugation, pre-cleared super-
natants were incubated at 4°C on a rotator, overnight, with 2µg of
each antibody, as indicated in figures. For co-immunoprecipitated
samples, goat normal IgG or rabbit normal IgG (Santa Cruz
Biotechnology) served as negative controls. Seventy microliters
of protein G-sepharose beads were then added and incubated
for an additional 60 min at 4°C on a rotator. The beads were
washed five times with 1% NP-40 lysis buffer containing 10 mM
Tris–HCl pH 7.8, 0.5 mM EDTA, 250 mM NaCl with protease
inhibitor cocktail, then boiled in Laemmli buffer and assayed by
immunoblot. Human primary CD4+ T cells were lysed in 200µl of
mammalian protein extraction reagent (M-PER; Pierce Biotech-
nology, Rockford, IL, USA) containing protease inhibitors (Roche
Diagnostics) and Halt™ phosphatase inhibitors (Thermo Fis-
cher Scientific). Thirty micrograms of protein was loaded for
western blotting. Band intensity was determined using ImageJ
Software (NIH).
GEL SHIFT MOBILITY ASSAYS (EMSA)
The NF-κB consensus binding site oligo was labeled with 32P fol-
lowing the manufacturer’s instructions (Promega, Madison, WI,
USA). Briefly, 2µl of the oligo (at 1.75 pmol/ml concentration)
was incubated with 1µl of 10× T4 polynucleotide kinase buffer
(700 mM Tris–HCl, pH 7.6, 100 mM MgCl2, 50 mM DTT), 1µl
of 32P γATP (3000 Ci/mmol at 10 mCi/ml), 5µl of autoclaved
dH2O, and 1µl of T4 polynucleotide kinase (5–10µ/ml) at 37°C
for 10 min. The reaction was stopped by adding 1µl of 0.5 M
EDTA and the total volume was brought up to 100µl by adding
89µl of TE buffer (10 mM Tris–HCl, pH 8.0, 1 mM EDTA). The
labeled oligo was carefully applied to the center of the column bed
of Sephadex G-50 column and centrifuged at 1100× g for 4 min
and radioactivity was assessed using a liquid scintillation counter.
About 5µg of nuclear extracts were incubated with 32P-labeled
NF-κB probes for 20 min at room temperature. The reactions
were generally in 9µl total volume containing 2µl of 5× gel
shift-binding buffer [20% glycerol, 5 mM MgCl2, 2.5 mM EDTA,
2.5 mM DTT, 250 mM NaCl, 50 mM Tris–HCl, pH 7.5, 0.25 mg/ml
poly (dI–dC)–poly (dI–dC)], nuclear extract, and nuclease-free
water. For super-shift assays, reactions were incubated for 2 h in the
presence of 2µg of indicated antibodies (Santa Cruz Biotechnol-
ogy). When labeled oligo was competed with excess same (NF-κB)
or unrelated (SP-1) unlabeled oligo, 1µl of unlabeled oligo was
added to the reaction and water volume was adjusted accordingly
to keep the reaction at 9µl total volume. The reaction mix was
incubated for 10 min at room temperature and then for another
20 min once the labeled oligo was added. The NF-κB and SP-1
consensus oligonucleotides were purchased from Promega. The
DNA–protein complexes were then mixed with 1µl of 10× gel
loading buffer (250 mM Tris–HCl pH 7.5, 0.2% bromophenol
blue, 40% glycerol) and subjected to electrophoresis in 4% acry-
lamide gels at 250 V at room temperature in cold 0.5× TBE buffer
(0.5 M Tris base, 0.4 M boric acid, 0.005 M EDTA, pH 8.0). Before
loading the gels with samples, the gels were pre-run for 30 min at
250 V at room temperature. The gels were dried and subjected to
autoradiography.
DUAL-LUCIFERASE REPORTER GENE ASSAY
Jurkat T cells were plated on 60 mm dishes and transfected
with the indicated expression vectors or with empty vector, as
a control. In the different experiments, we used 0.4µg of NF-
κBx3 luc as the reporter plasmid and 0.1µg pRL-CMV as the
internal control. Luciferase assays (Dual-Luciferase Assay Sys-
tem, Promega) were performed 48 h after transfection, accord-
ing to the manufacturer’s instructions. Before harvest, trans-
fectants were stimulated for 3 h with phorbol 12-myristate
13-acetate (PMA) and calcium ionophore (CaI) both from
Sigma-Aldrich at 80 and 500 nM, respectively. Luciferase val-
ues were normalized against Renilla luciferase activity. A min-
imum of three independent experiments were performed, in
duplicate.
LENTIVIRAL TRANSDUCTION WITH NOTCH1 shRNA
293T cells were seeded in 100 mm culture dishes (3× 106 per
dish) 1 day prior to transfection. The transfection mixture com-
plexes were prepared by mixing together 100µl serum-reduced
OPTI-MEM (Invitrogen), 36µl FuGENE6® (Roche Diagnostics),
12µg of DNA (6µg pRRL-shNOTCH1, 3µg pHCMV-G, and 3µg
pCMV∆R8.2) and incubating at room temperature for 20 min.
The transfection mixture was added to 1 ml complete media and
then transferred onto 293T cells. After 24 h of incubation, DNA-
transfection medium was replaced with fresh culture medium.
The lentiviral culture supernatants were harvested 48 h post-
transfection. Jurkat T cells were plated for lentiviral infection at
1× 107 per 100 mm dish in 1 ml of culture media, 10 ml of 0.4µm
filtered lentiviral culture supernatants, and 10µg/ml polybrene.
After 24 h of infection with lentiviral supernatant, 20 ml of fresh
RPMI media containing 10% FBS, 10µM β-mercaptoethanol,
penicillin/streptomycin, gentamicin, and 0.5µg/ml of puromycin
was added and cells were and selected for 72 h post-infection. Cells
were assayed for successful reduction of endogenous expression of
NOTCH1 by immunoblotting. For human PBMCs, cells were cul-
tivated in 37°C incubator and 5% CO2 in RPMI 1640 medium
supplemented with 10% FBS (Hyclone), penicillin–streptomycin,
2 mM glutamine, 1 mM pyruvate, 10 mM HEPES, and 0.1 mM
non-essential amino acids. CD4+ T cells were stimulated by
anti-CD3ε and CD28-coated beads (Invitrogen/Life Technologies)
using one bead per cell. For shRNA experiments, freshly isolated
CD4+T cells were transfected with scrambled control shRNA or
NOTCH1 shRNA (Santa Cruz Biotechnology) using the Amaxa
Nucleoporator system according to manufacturer’s instructions.
CD4+ cells (5–10× 106) were resuspended in 100µl of nucleo-
fection solution and transfected with 100 nM shRNA using U-014
nucleofector program (Lonza Group, Worldwide). After transfec-
tion, cells were incubated for 6 h at 37°C then fresh medium was
added. After 24 h, transfected cells were stimulated with anti-CD3ε
and CD28-coated beads (Invitrogen/Life Technologies). Trypan
blue exclusion assay was performed to ensure cells’ viability after
nucleoporation.
STATISTICAL ANALYSES
Data are represented as means+ SEM. Analyses were performed
using Prism software (GraphPad) with a one-way ANOVA with
Tukey’s post-test applied. P < 0.05 was considered significant.
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RESULTS
NOTCH1 AND PKCθ ACT WITHIN THE SAME FUNCTIONAL PATHWAY TO
MEDIATE SKIN ALLOGRAFT REJECTION
T cell receptor engagement together with co-stimulation through
CD28 will fully activate peripheral T cells, an event that requires
phosphorylation of the T cell-specific kinase, PKCθ. T cells from
transgenic mice deficient in PKCθ do not exhibit a characteristic
activation phenotype. Instead, they fail to upregulate CD25, the
high-affinity IL-2 receptor, exhibit faulty NF-κB activity, and show
reduced levels of IL-2 production (1). PKCθ has been previously
described to play an essential role in activating the classical NF-κB
signaling cascade (14). Interestingly, when peripheral T cells defi-
cient in NOTCH1 signaling are stimulated through the TCR, they
exhibit a similar phenotype of dampened T cell activation (16–19,
23). This observation led us to ask whether PKCθ and NOTCH1
cooperate within the same signaling cascade to direct full T cell
activation and subsequent downstream effects.
We tested this functional interaction, in vivo, using a murine
model of skin allograft rejection. Full acceptance of BALB/c car-
diac allografts can be induced in C57BL/6 recipients when CD4+
T cell-intrinsic, classical NF-κB signaling is inhibited. By contrast,
BALB/c skin allografts are fully rejected, albeit with delayed kinet-
ics, when transplanted onto C57BL/6 mice displaying deficient
classical NF-κB activity (27). Since we hypothesized that NOTCH1
and PKCθ may be operating within the same cascade to facilitate
NF-κB activation, we predicted that inhibiting the activities of
either or both proteins in recipient mice would delay skin allograft
rejection in this transplantation model, but would not prevent it
fully. We established our baseline time to full rejection by transfer-
ring skin from a BALB/c donor onto a wild-type C57BL/6 recipient
(Figure 1A). When skin from a BALB/c donor was grafted onto
C57BL/6 mice deficient in the p50 subunit (p50null), which is
required for classical NF-κB activation, graft rejection was sig-
nificantly delayed compared to controls (Figures 1B,G). We used
this second point of reference as the average time to rejection when
classical NF-κB signaling in recipient mice is impaired. We next
assessed how the loss of PKCθ affected graft rejection by trans-
planting skin allografts from BALB/c mice onto PKCθnull C57BL/6
recipients. The delay in allograft rejection was identical to that
seen in p50null allograft recipients (Figures 1B,C,G), confirming
that inhibiting either PKCθ or p50 produce identical kinetics of
skin graft rejection. We then determined what effect inhibiting
NOTCH signaling had on skin allograft survival in this model.
We genetically deleted NOTCH1 in peripheral immune cells of
NOTCH1fl/fl recipient mice using cre-lox technology (23), or we
inhibited NOTCH activity, pharmacologically, by treating recip-
ient mice with a GSI, to prevent the final cleavage and nuclear
translocation of NOTCH receptors. We then transplanted skin
from BALB/c donors and followed the time to rejection. Our
results show that mice deficient in NOTCH1 signaling (N1KO
or +GSI) exhibited the same rejection kinetics as seen with the
p50null or the PKCθnull allograft recipients (Figures 1D,E,G). We
reasoned that if NOTCH1 and PKCθ function in the same signaling
cascade, we would still observe graft rejection, even if both proteins
were simultaneously inhibited. To test this hypothesis, we blocked
NOTCH signaling in PKCθnull recipient mice by administering GSI
formulated in rodent chow then grafted BALB/c skin onto these
NOTCH-inhibited, PKCθnull mice. As shown in Figures 1C,F,G,
PKCθnull mice show comparable kinetics of graft rejection regard-
less of whether NOTCH1 signaling was inhibited using GSI chow,
providing evidence that NOTCH and PKCθ may operate in the
same functional pathway in a murine model of skin allograft
rejection.
NOTCH ASSOCIATES WITH PKCθ IN ACTIVATED T CELLS
In regulatory T cells, intracellular NOTCH1 (N1IC) has been
shown to physically associate in the cytosol with RICTOR to
potentiate cell survival during cytokine withdrawal (20–22). An
intriguing extension of these data would propose that sub-cellular
localization may be one means by which NOTCH1 mediates its
diverse effects during T cell activation. Motivated by our in vivo
observations, we went on to explore the possibility that PKCθ and
NOTCH1 physically cooperate in a T cell-intrinsic fashion to direct
full T cell activation.
To address this question, we incubated WT CD4+ T cells from
C57BL/6 mice for 15–30 min with Dynal beads pre-coated with
anti-mouse CD3ε and anti-mouse CD28. We then stained cells
with antibodies specific for NOTCH1 and PKCθ and used confocal
microscopy to examine their sub-cellular localization. As shown
in Figure 2A, NOTCH1 and PKCθ co-localize at the bead–cell
interface, placing them together temporally and spatially within
minutes of T cell activation. We next used biochemical meth-
ods to assess the physical interaction between NOTCH1 and
PKCθ in activated human T cells. Utilizing immunoprecipita-
tion, we could detect NOTCH1 bound to PKCθ as early as 1 h
after stimulating human Jurkat T cells with anti-human CD3ε and
anti-human CD28, and this association increased in intensity by
3 h (Figure 2B; Figure S1 in Supplementary Material). Cleaved
NOTCH1 drives its own expression (28), and we previously deter-
mined that NOTCH1IC can be detected in T cells 6–8 h following
stimulation (Osborne, unpublished). This expression requires new
protein synthesis, since pulsing cells with cycloheximide prevents
NOTCH1IC accumulation (data not shown). However, the rapid
kinetics of co-localization and complex formation we detected by
our combined microscopy and biochemical approaches indicate
that the NOTCH1–PKCθ complexes we detected within an hour
of stimulation result from the association of pre-existent proteins
expressed in T cells at the time of TCR activation.
NOTCH1 PHYSICALLY INTERACTS WITH COMPONENTS OF THE CBM
Following TCR–CD28 stimulation, PKCθ translocates to the site
of TCR clustering known as the immunological synapse (IS) and
triggers the recruitment of CARMA1 and BCL10 to lipid rafts (29,
30). NOTCH1 has also been shown to localize to the IS and to
associate with PI3K and p56Lck in activated T cells at the site of
TCR clustering (31). Collectively, these observations place PKCθ
and NOTCH1 in the same cellular location as the CBM complex
during T cell activation. Since studies show PKCθ associates with
and phosphorylates CARMA1 (1, 3), we further explored the pos-
sibility that NOTCH1 also interacts physically with CARMA1. To
do so we used Jurkat human T cells, which endogenously express
NOTCH1 together with signaling components necessary for CBM
complex assembly. Lipid rafts were isolated by ultracentrifugation
over a discontinuous sucrose gradient from lysates of Jurkat T
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FIGURE 1 | NOTCH1 and PKCθ act in the same functional pathway to
mediate allograft rejection. We monitored the influence on rejection
kinetics of murine skin allografts by recipient mice deficient for various
proteins. Grafts were visually scored for signs of rejection using a scale of
1–10, with 1 being completely rejected. An allograft was considered fully
rejected when it was >80% necrotic. Graphs represent allograft score (y
axis), with a score of “1” being fully rejected and a score of “10” being fully
accepted versus time in days after skin grafting (x axis). Wild-type BALB/c
skin was grafted onto (A) wild-type C57BL/6 mice (BALB/c→BL6), which
served as a baseline for graft rejection for subsequent allograft
combinations; (B) p50null mice (BALB/c→p50null); (C) PKCθnull mice
(BALB/c→PKCθnull); (D) NOTCH1 conditional knock-out (N1KO) mice
(BALB/c→N1KO); (E) wild-type C57BL/6 mice whose NOTCH signaling
was abrogated by administering γ-secretase inhibitor (GSI LY411,575;
BALB/c→WT+GSI); and (F) PKCθnull mice whose NOTCH signaling was
abrogated by administering γ-secretase inhibitor (GSI LY411,575) in chow
(BALB/c→PKCθnull +GSI). (G) Day to complete rejection was compared
between different groups of recipient mice. For each animal grafted with
BALB/c skin, an internal control of C57BL/6 skin was also grafted
(BL6→BL6) to monitor integrity of the grafting technique. Data represent
the mean+SEM (n=3–16 mice/group). ***P <0.001; one-way ANOVA
with Tukey’s post-test applied.
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FIGURE 2 | NOTCH1 associates with PKCθ in stimulatedT cells.
NOTCH1 and PKCθ co-localize and interact following T cell stimulation.
(A) Purified CD4+ T cells from C57BL/6 mice were incubated for 30 min
with Dynal beads pre-coated with anti-mouse CD3ε and anti-mouse CD28
on glass slides. Cells were fixed, quenched, permeabilized, blocked, and
stained with antibodies to NOTCH1 (green) and PKCθ (red). Proteins were
visualized using species-specific, fluorescently conjugated secondary
antibodies. *Indicates bead. (B) Jurkat T cells were stimulated with
plate-bound anti-human CD3ε and anti-human CD28 for the indicated time
periods, and subjected to co-immunoprecipitation with anti-NOTCH1.
Immunoprecipitates (upper panel) and 1/100 of input (lower panels) were
immunoblotted with anti-PKCθ and anti-NOTCH1. Data are representative of
at least three independent experiments.
cells. Nine fractions, in total, were collected and all were tested
in dot blots with anti-CTX conjugated with HRP. The 12,000 Da,
non-toxic B subunit of CTX binds specifically to the pentasac-
charide moiety of ganglioside GM1, a glycosphingolipid predom-
inantly associated with lipid rafts (31, 32). As shown in Figure 3A,
upper panel, further analysis by immunoblotting revealed that
the lipid raft marker GM1 was exclusively detected in the lipid
raft-containing,higher-numbered fractions (No. 4–9),whereas the
lower-numbered fractions (No. 1–3) which contain soluble mem-
brane proteins, showed undetectable levels of sphingolipid GM1.
When the fractions indicated were pooled and immunoblotted
with antibodies specific for NOTCH1 or CARMA1 we observed,
in unstimulated Jurkat T cells, the majority of CARMA1 co-
localized with NOTCH1 in the soluble fractions (Figure 3A, lower
panels, No. 1–3). However, in fractions obtained from Jurkat T
cells stimulated with anti-human CD3ε and anti-human CD28, a
FIGURE 3 | NOTCH1 interacts with CARMA1 and BCL10 following
stimulation with anti-CD3ε and anti-CD28. (A) Jurkat T cells were
stimulated with plate-bound anti-human CD3ε and anti-human CD28 and
subjected to sucrose gradient centrifugation. All fractions were analyzed by
dot blot with anti-cholera toxin-conjugated HRP (upper panel). Pooled
fractions were immunoblotted with indicated antibodies (lower panel).
(B) Jurkat T cells were stimulated as in (A) for the indicated time periods,
followed by co-immunoprecipitation with antibodies specific for NOTCH1,
CARMA1, or BCL10. Eluates were subjected to immunoblotting with
indicated antibodies. 1/100 of input (shown) was immunoblotted with
anti-CARMA1, anti-BCL10, and anti-NOTCH1. Arrow heads beside IB:
NOTCH1 represent 120 kDa, transmembrane form (upper arrow head) and
110 kDa intracellular form (lower arrow head) of NOTCH1. Data are
representative of at least three independent experiments.
portion of CARMA1 could be found in the lipid raft fractions
(Figure 3A, lower panels, No. 7–9), where it also co-localized
with NOTCH1. To determine whether this redistribution involved
direct interaction between these molecules, Jurkat T cells were
stimulated with antibodies for the indicated time periods, har-
vested, and whole cell lysates were co-immunoprecipitated using
antibodies specific for NOTCH1, CARMA1, or BCL10. Consistent
with earlier reports (26), CARMA1 co-immunoprecipitated with
BCL10 in stimulated Jurkat T cells (Figure 3B; Figure S2C in Sup-
plementary Material). In addition to binding BCL10, CARMA1
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also associated strongly with NOTCH1 (Figure 3B; Figures S2A,B
in Supplementary Material), regardless of which protein was the
target of the immunoprecipitating antibody. We further con-
firmed NOTCH1- and CARMA1-interactions with BCL10 by co-
immunoprecipitating with anti-BCL10 (Figure 3B; Figures S2D,E
in Supplementary Material). Intriguingly, CARMA1 was associ-
ated both with membrane-bound NOTCH1 (~120 kDa, upper
arrowhead) and the intracellular domain of NOTCH1 (~110 kDa,
lower arrowhead) as shown in Figure 3B, with CARMA1 show-
ing increasing binding over time to the intracellular domain of
NOTCH1IC.
Although a cytosolic role for NIC1 has been reported in reg-
ulatory T cells (20–22), no such evidence has yet been offered in
support of a cytosolic function for N1IC during normal T cell
activation. Therefore, we sought to further confirm NOTCH1–
CARMA1 association in the cytoplasm of T cells using an alternate
approach. Various means exist for determining protein–protein
interactions including fluorescence resonance electron transfer
(FRET) and enzyme fragment complementation methods (33,
34). More recently, bimolecular fluorescence complementation
(BiFC) assays have been developed to interrogate physical inter-
action between proteins (35, 36). In this approach, a whole flu-
orescent reporter molecule is expressed as two complementary
fragments, each in an individual plasmid, and each linked to
one of two proteins of interest. When both plasmids are co-
transfected into a cell line, the fluorescent reporter molecule will
be reconstituted only if the two proteins of interest physically
associate. We validated our approach using BiFC in Jurkat T
cells, by co-expressing plasmids containing cFOS (pBiFC–cFos–
YC155) and cJUN (pBiFC–cJun–YN155), whose interaction in
the nucleus is well-documented. As shown in Figure 4A, co-
expression of cFOS and cJUN results in fluorescence comple-
mentation and its detection in the nucleus. No fluorescence was
detected in the nucleus when pBiFC–cJun–YC155 was expressed
together with a plasmid encoding NOTCH1IC that was targeted
either to the nucleus (pBiFC–N1IC–NLS–YC155; Figure 4B) or
to the cytosol (pBiFC–N1IC–NES–YC155; Figure 4C) by the
addition of a NLS or a NES, respectively. We next transfected
Jurkat T cells with the following combinations of constructs:
(i) pBiFC–N1IC–NES–YC155 and pBiFC–CARMA1–YN155, (ii)
BiFC–N1IC–NLS–YC155 and pBiFC–CARMA1–YN155, or with
(iii) pBiFC–N1IC–NES–YC155 alone, to ask whether CARMA1
and NOTCH1 are capable of binding to each other in the
cytosol. Twenty-four hours after transfection, cells were incu-
bated with anti-human CD3ε and anti-human CD28. Receptor-
bound antibody was cross-linked using anti-goat IgG and fluores-
cent images of live Jurkat T cells were acquired using confocal
microscopy. As shown in Figure 4D, fluorescence was recon-
stituted in cells which expressed CARMA1 together with the
cytoplasmically restricted NOTCH1 (pBiFC–N1IC–NES–YC155),
but not in cells expressing CARMA1 and the nuclear-targeted
NOTCH1 construct (pBiFC–N1IC–NLS–YC155; Figure 4E) or
in cells expressing pBiFC–N1IC–NES–YC155 in the absence of
pBiFC–CARMA1–YN155 (Figure 4F). Therefore, using two dis-
tinct approaches to interrogate their physical interaction in human
T cells, we show for the first time that, following anti-human
CD3ε and anti-human CD28 stimulation, NOTCH1 can associate
with CARMA1, a component of the cytoplasmically restricted,
CBM complex.
NOTCH1 INFLUENCES THE FORMATION OF THE CBM COMPLEX
CARMA1 co-precipitates with the TCR, and is recruited to lipid
rafts enriched in PKCθ (26). CARMA1 phosphorylation is likely
mediated by PKCθ, following its own phosphorylation by GLK (1,
2, 4, 7). Once phosphorylated, CARMA1 associates with the down-
stream scaffold/adapter molecules, BCL10 and MALT1, recruiting
these molecules into the lipid rafts of the IS and, ultimately, lead-
ing to activation of NF-κB (30). Although we could demonstrate
that NOTCH1 physically interacts with CARMA1 and BCL10
(Figures 3 and 4), it remained unclear whether this association
was necessary for, or was the result of, CBM complex forma-
tion. To ask whether NOTCH1 was required for the assembly of
the CBM complex, we infected Jurkat T cells with lentiviral con-
structs corresponding to shRNA to NOTCH1 (NOTCH1-knock-
down Jurkat). These cells exhibited reduced NOTCH1 expression
inversely proportional to the concentration of lentiviral super-
natant in the culture media (Figure 5A). To test whether reducing
the level of endogenous NOTCH1 abrogated CBM complex for-
mation, whole cell lysates from NOTCH1-knock-down or mock-
infected Jurkat T cells were immunoprecipitated with antibodies
specific for NOTCH1, CARMA1, or BCL10, then immunoblot-
ted with antibodies specific for CARMA1 or BCL10 (Figure 5B;
Figures S3A–D in Supplementary Material). In the absence of
NOTCH1, CARMA1 failed to associate with BCL10, compared to
mock-infected controls, indicating that NOTCH1 is indispensable
for the interaction between CARMA1 and BCL10.
To test whether the deficiency of endogenous NOTCH1 pre-
vents association of PKCθ with the CBM complex, NOTCH1-
knock-down Jurkat T cells or mock-infected controls were stimu-
lated with plate-bound anti-human CD3ε and anti-human CD28.
T cell lysates were then co-immunoprecipitated with antibodies
specific for CARMA1 or PKCθ. As shown in Figure 5C and in
Figures S4A–C in Supplementary Material, CARMA1 interacts
both with PKCθ and BCL10 in the mock-infected controls. In
contrast, NOTCH1 deficiency resulted in greatly diminished inter-
actions between CARMA1 and PKCθ, as well as between PKCθ
and BCL10, even following anti-human CD3ε and anti-human
CD28 co-stimulation. To demonstrate that NOTCH1 shRNA does
not inhibit all signaling events downstream of TCR activation, we
examined the phosphorylation pattern of additional molecules
known to be differentially phosphorylated following TCR activa-
tion. In Jurkat T cells with NOTCH1-knock-down, as expected,
we observed decreased expression of phosphorylated ERK com-
pared to mock-infected controls. However, phosphorylation of
p38 MAPK remained unchanged following stimulation with anti-
human CD3ε and anti-human CD28 (Figure 5D; Figures S5A,D–
G in Supplementary Material). Additionally, and consistent with
our previous results, phosphorylation of IκBα was significantly
decreased in Jurkat cells transfected with NOTCH1 shRNA, while
the level of total IκBα remained unchanged (Figures S5B,C in
Supplementary Material). Functionally, this translated into a
diminished NF-κB–DNA binding capacity, as compared to mock-
infected controls, when DNA binding was measured using an
electrophoretic mobility shift assay (Figure 5E). Thus, inhibiting
Frontiers in Immunology | T Cell Biology May 2014 | Volume 5 | Article 249 | 8
Shin et al. Cytosolic NOTCH1 can initiate NF-κB signaling
FIGURE 4 | Cytosolic N1IC can interact with CARMA1 in a
bifluorescence complementation assay. Jurkat T cells were transfected
with various constructs of nuclear and/or cytosolic proteins and their
physical association was assessed microscopically by their ability to
reconstitute two halves of a yellow fluorescent protein reporter.
Twenty-four hours after transfection, cells were plated onto glass bottom
culture dishes, stimulated with anti-human CD3ε and anti-human CD28,
and fluorescent images of live cells were captured using a Zeiss LSM 510
confocal microscope. (A) Nuclear proteins, cFos and cJun, known to
interact in the nucleus were co-expressed as a control; (B) NOTCH1 with
an additional nuclear localization signal, N1IC–NLS was co-expressed with
nuclear cJun; (C) NOTCH1 with an additional nuclear export signal,
N1IC–NES, was co-expressed with nuclear cJun; (D) NOTCH1 with an
additional nuclear export signal, N1IC–NES was co-expressed with
CARMA1, a cytosolic protein; (E) NOTCH1 with an additional nuclear
localization signal, N1IC–NLS was CARMA1; (F) NOTCH1 with an
additional nuclear export signal, N1IC–NES was expressed alone. Upper
panel of all images represent fluorescent channel only; lower panel of all
images represent merged fluorescent and DIC images. Data are
representative of at least three separate experiments.
NOTCH1 expression using shRNA approaches had a significant
effect on phosphorylation of IκBα, a critical step in the NF-
κB activation cascade, as well as functionally, on NF-κB–DNA
interactions, but showed little or no effect on other targets of
the TCR signaling pathway such as phosphorylation of p38.
Taken together, these data suggest that NOTCH1 may influence
early NF-κB activation in stimulated T cells through its func-
tion as a scaffold protein and its potential recruitment by PKCθ
to the CBM complex, upstream of IKK activation and IκBα
phosphorylation.
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FIGURE 5 | NOTCH1 deficiency prevents the formation of the CBM
complex. (A) NOTCH1 expression was efficiently reduced when Jurkat T
cells were incubated with viral supernatants. NOTCH1-knock-down Jurkat T
cells, or mock-infected control cells, were stimulated with plate-bound
anti-human CD3ε and anti-human CD28 for 1 h, harvested for
co-immunoprecipitation with indicated antibodies, then subjected to
immunoblotting with (B,C) anti-NOTCH1, anti-CARMA1, anti-BCL10, or
anti-PKCθ; 1/100 of input was immunoblotted with indicated antibodies, or
with (D) antibodies specific for NOTCH1, phosphorylated and total IκBα,
phosphorylated and total ERK, and phosphorylated and total p38 MAPK.
(E) NOTCH1-knock-down Jurkat T cells, or mock-infected control cells, were
stimulated with plate-bound anti-human CD3ε and anti-human CD28 for the
times indicated. EMSAs were performed on nuclear extracts using
radiolabeled oligonucleotides containing the NF-κB binding sequence. Red
filled diamond represents competition with cold probe. Data are
representative of at least three independent experiments.
FUNCTIONAL DOMAINS OF N1IC MEDIATE ITS INTERACTION WITH
CARMA1
NOTCH signal strength is thought to be tightly regulated by pro-
teins such as Numb, Deltex1, and several E3 ubiquitin ligases,
as well as through intra-membrane NOTCH-receptor proteolysis
after binding with ligand(s) expressed on neighboring cells (37–
39). The intracellular portion of NOTCH1 contains two protein–
protein interaction domains, the RAM domain, and the ankyrin
(ANK) repeats, two NLS, a trans-activation domain (TAD) which
is important in NOTCH1- and NOTCH2-regulated transcrip-
tion but is absent from NOTCH3 and NOTCH4, and a PEST
sequence, important for regulating NOTCH degradation (15).
NOTCH down-stream effects are governed by binding and mod-
ulating proteins, and may be mediated by specific domains of
NOTCH1. We found that only when NOTCH1 was retained
in the cytoplasm could it bind to CARMA1 (Figure 4D). To
define the sites of interaction between NOTCH1 and CARMA1,
we obtained fluorescent fusion chimeras of NOTCH1 (GFP–
N1IC), mutated the constructs, and verified their cellular local-
ization in 293T cells (Figure 6A). Adding an additional NES
sequence to GFP–N1IC mutants promoted their cytosolic reten-
tion (Figure 6A), compared to N1IC mutants lacking the addi-
tional NES. To identify those domain(s) of NOTCH1 required for
its interaction with CARMA1, we co-transfected these mutants
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FIGURE 6 |The RAM domain of NOTCH1 mediates its interaction with
CARMA1. (A) GFP–N1IC mutant expression plasmids were transfected
into 293T cells and sub-cellular localization of NOTCH1 was examined using
fluorescence microscopy. (B) VSV–CARMA1 expression plasmids were
transiently co-transfected with GFP empty vector as a control, or with
GFP–N1IC mutant plasmids in 293T cells, as indicated. Transfected cells
were harvested and cell lysates were co-immunoprecipitated with
antibodies specific for GFP. Co-immunoprecipitated proteins were then
immunoblotted with anti-VSV or anti-GFP. Ig heavy chain indicates
immunoglobulin heavy chain.
together with VSV-tagged WT CARMA1, into 293T cells and co-
immunoprecipitated with antibodies specific for GFP. We detected
interaction between CARMA1 and all N1IC–NES mutants except
N1IC∆RAM–NES, which showed strongly reduced binding, even
though its expression was restricted to the cytosol (Figure 6B).
These data demonstrate that the N-terminal region of N1IC,
including the RAM domain, is required for the interaction of N1IC
with CARMA1, and this association likely occurs in the cytoplasm.
CYTOSOLIC NOTCH1 INTERACTS WITH CARMA1 TO ENHANCE
TRANSCRIPTIONAL ACTIVITY OF NF-κB
Canonical signaling by N11C is mediated by its effects on tran-
scription in cooperation with the DNA binding protein, CSL
(40). Translocation of N1IC to the nucleus leads to formation
of N1IC/CSL complexes on the promoters of NOTCH-regulated
genes. This further facilitates recruitment of transcriptional co-
activators, such as p300, and the subsequent initiation of tran-
scription. CARMA1 and the CBM complex, however, are thought
to function exclusively in the cytosol. Previous studies by other
groups have highlighted the contribution of CARMA1 and BCL10
to NF-κB-dependent gene expression in Jurkat T cells following
stimulation with PMA and CaI or with anti-human CD3ε and anti-
human CD28 (2, 26, 41). However, an integral role for NOTCH1
in mediating this process (Figures 3–5) has not been previously
described. We expressed nuclear- and cytosolic-directed N1IC
constructs in 293T cells and verified their cellular distribution
(Figures 7A,B). We then sought to determine how cellular localiza-
tion of N1IC influences its interactions with CARMA1 to regulate
NF-κB activation. We co-transfected CARMA1, cytoplasmically
expressed N1IC–NES, or a membrane-tethered, non-cleavable
form of N1IC (N1∆E–PM),either individually or together,with an
NF-κB luciferase reporter construct into Jurkat T cells. Cells were
then left unstimulated or stimulated for 3 h with PMA and CaI. We
determined NF-κB activity using a luciferase reporter gene assay.
Expression of CARMA1 alone induced NF-κB reporter activity
~15-fold (Figure 7C, lane 3), consistent with previous reports.
PMA and CaI stimulation further increased reporter activity an
additional four to fivefold, compared to unstimulated controls
(Figure 7C, lane 4). When we expressed constructs of N1IC–
NES or N1∆E–PM individually, or together with CARMA1, in
the absence of stimulation we detected only basal levels of NF-
κB activity (Figure 7C, lanes 5, 7, 9, 11). This activity increased
in stimulated Jurkat T cells expressing either of these constructs,
individually (Figure 7C, lanes 6, 8). Altogether, these results are
consistent with the fact that events that occur during T cell stimu-
lation are important for downstream NF-κB activation. However,
when cytosolic N1IC–NES or membrane-tethered N1∆E–PM was
expressed together with CARMA1 and cells were stimulated with
PMA and CaI, we observed an additive effect on NF-κB activ-
ity (Figure 7C, lanes 10, 12), compared to expression of either
construct alone in stimulated cells. Collectively, these data suggest
that cytosolic and/or membrane-bound NOTCH1 is capable of
activating NF-κB at time points that precede NOTCH1 nuclear
accumulation and, thus, may reveal a novel non-nuclear function
for NOTCH1 soon after T cell stimulation.
DISCUSSION
Scaffold proteins have emerged as key orchestrators of multi-
component signaling complexes in many systems, including
immune cells (42, 43). They function as central organizers to con-
trol a series of signal transduction cascades and mediate complex
assembly by coordinating protein–protein interactions. NOTCH
cell surface receptors are highly conserved type I transmem-
brane proteins. The N1IC intracellular fragment is comprised of
domains that mediate protein–protein interaction, transcriptional
activation, and proteolytic degradation. Ligand binding induces
a series of enzymatic cleavages to generate N1IC allowing it to
translocate to the nucleus. A large body of data describes its essen-
tial role in the transcription of target genes. Recent new studies
point to novel contributions of N1IC in mediating regulatory
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FIGURE 7 | NOTCH1 increases NF-κB activity through its direct
interaction with CARMA1 in the cytoplasm. (A) 293T cells were transiently
transfected with GFP-N1IC–NLS or GFP-N1IC–NES and sub-cellular
localization was determined using fluorescence microscopy. (B) CARMA1
expression plasmids were transiently co-transfected with GFP empty vector
as a control, or with GFP-N1IC–NLS or GFP-N1IC–NES in 293T cells.
Cytoplasmic extracts from transfected cells were co-immunoprecipitated with
anti-GFP. 1/100 of input (shown) was immunoblotted with anti-VSV and
anti-GFP. (C) Vectors expressing cytosolic N1IC–NES, membrane-tethered
N1∆E–PM, and/or cytosolic CARMA1 were co-transfected with an NF-κB
luciferase reporter construct into Jurkat T cells, stimulated with PMA and CaI
for 3 h, then subjected to a luciferase reporter gene assay. Ig heavy chain
indicates immunoglobulin heavy chain. Data are mean+SEM of at least three
independent experiments.
T cell survival, a function that did not require its nuclear redis-
tribution (20–22). Here, we utilized microcopy and biochemical
approaches to demonstrate a cytoplasmic role for N1IC during
the first few hours following T cell activation. In stimulated T
cells, N1IC associated with members of the CBM complex, a
cytosolic supramolecular structure that relays signals from the
TCR. Loss of NOTCH1 expression prevented CBM assembly,
abrogated IκBα phosphorylation, and diminished NF-κB bind-
ing at early time points. These observations are consistent with
what is known about the requirement for the CBM signalosome
upstream of classical NF-κB activation. In earlier reports, we uti-
lized an GSI to prevent NOTCH cleavage and translocation, and
showed it blocked NF-κB nuclear accumulation at the later (12 h
post-stimulation) but not the earlier (first 6 h post-stimulation)
time points (19). Surprisingly, in this study, we found strong NF-
κB transcriptional activity within 3 h of T cell stimulation when
N1IC was expressed in a form that confined it to the cytosol, or
even when it was tethered to the membrane. Altogether, these data
support a model whereby N1IC acts to nucleate the CBM complex
and initiate NF-κB signaling downstream of TCR engagement, a
cytosolic function which has not previously been described for
N1IC. In light of these new data, we offer a refined interpretation
of our earlier observations (19). We propose that non-nuclear
N1IC may aid in initiating NF-κB signaling in stimulated T cells,
but cleaved, nuclear-residing N1IC is required to sustain NF-κB
activity at later time points. This two-tiered signaling model would
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provide a self-reinforcing feedback loop to ensure optimal NF-κB
activation.
Earlier studies have identified PKCθ as necessary for initiating
the signaling cascade that culminates in classical NF-κB activation
(14). Within the context of the present study, therefore, we sought
to ask two major questions. We were interested in knowing whether
NOTCH1 acts in the same functional pathway as PKCθ and, if so,
could we identify spatial and temporal events that defined their
mutual regulation of NF-κB activation?
To answer the first question, we employed a murine model
of skin allografting, which requires inhibition both of classical
and non-classical NF-κB signaling in recipient mice to completely
attenuate graft rejection (27). In the absence of the p50 subunit
of NF-κB, which requires intact PKCθ signaling to translocate to
the nucleus (44), we noted delayed, but not completely inhib-
ited, graft rejection. Furthermore, when we transferred skin from
BALB/c donors to recipient mice which lacked PKCθ, NOTCH1,
or both, the kinetics of graft rejection were identical to those seen
in the p50null recipient. Altogether, these observations suggested
to us that PKCθ and NOTCH1 were both acting in the same func-
tional pathway in T cells in a mouse model of allograft rejection,
and loss of either or both of these proteins produced the same
rejection kinetics as loss of p50. Functional interaction between
NOTCH receptors and PKC family members has been previously
noted. NOTCH3IC and PKCθwere shown to cooperate to increase
NF-κB signaling in thymocytes, leading to leukemogenesis (45).
Although direct interaction between NOTCH3IC and PKCθ was
not demonstrated in that study, NOTCH3IC expression enhanced
membrane translocation of PKCθ, which also required expres-
sion of pre-TCR, and expression of all of these components were
required to initiate NF-κB signaling, as measured by the nuclear
translocation of NF-κB subunits.
Upon TCR engagement, CARMA1 is redistributed into lipid
rafts and recruited to the IS, along with BCL10 via CARD–CARD
interaction (3). Previous studies using amino acid substitution
revealed those domains of CARMA1 that are capable of mediat-
ing protein–protein interactions and, thus, defined it as a scaffold
protein (46). The SH3 domain of CARMA1 is important for
its recruitment into lipid rafts, where it may function to fur-
ther recruit signaling molecules into supramolecular structures
targeted to the IS. We found that NOTCH1 also accumulated
in lipid rafts in activated T cells. This is consistent with reports
that, following T cell stimulation, endogenous NOTCH1 directly
associates with proteins enriched in lipid rafts, such as p56Lck,
CD4, and PI3K, both in Jurkat T cells and in in vitro-activated
splenic T cells (31, 47). We observed that NOTCH1 physically
associated with CARMA1 and BCL10 following T cell stimulation.
Using bifluorescence complementation, we further confirmed that
CARMA1 and NOTCH1 are capable of physically interacting in
the cytosol.
NOTCH1-deficient cells failed to form a CBM complex, a phe-
nomenon that, to the best of our knowledge, has not previously
been described. NOTCH1 deficiency did not alter endogenous
levels of CARMA1 or BCL10, thus it is unlikely that faulty CBM
complex assembly in the absence of NOTCH was due to reduced
expression either of CARMA1 or BCL10. A critical step in the for-
mation of the CBM complex is phosphorylation both of CARMA1
and BCL10. How NOTCH1 may influence phosphorylation of
either or both proteins remains to be investigated. It has been
reported that CARMA1 is inducibly phosphorylated by PKCθ (1,
11, 48), and we did not observe physical association of PKCθ
either with CARMA1 or BCL10 in the absence of NOTCH1. It
has been hypothesized that CARMA1 is tethered to the membrane
by an unknown protein (1). Although not the focus of this study,
it is intriguing to speculate that NOTCH1 may serve this func-
tion. If NOTCH1 and CARMA1 exist in preformed complexes
in unstimulated T cells, their recruitment into the IS following
T cell stimulation would bring them both into close proximity
to PKCθ, perhaps stabilizing the interaction between PKCθ and
CARMA1, and facilitating PKCθ phosphorylation of CARMA1.
This model is consistent with our observations that NOTCH1 is
necessary for CBM complex assembly, as is T cell stimulation,
although additional experiments are necessary to confirm this
hypothesis.
To identify the critical domains of NOTCH1 required for medi-
ating direct interaction with CARMA1, we fused additional NES
sequences to N1IC mutants (19, 25) in order to redirect these
proteins to the cytoplasm. We chose this approach rather than
mutating the NLS sites of N1IC, since it has been reported that
neither mutation nor deletion of the two NLS domains in N1IC
completely abolishes nuclear distribution (49). This concurs with
early studies showing the ANK repeat region also has some intrin-
sic capacity for nuclear localization (25, 49, 50). Of the N1IC
mutants we tested, only the N1IC∆RAM construct diminished
CARMA1 binding when it was exported to the cytoplasm using
an NES tag. Intriguingly, although the N-terminal region of N1IC
has been shown to mediate its interaction with RBP-Jκ or NF-κB
(19, 50), here it is also unexpectedly responsible for its interac-
tion with CARMA1. Additional studies will be needed to define
the region(s) of CARMA1 that are required for its association
with N1IC.
N1IC binding to other cytosolic proteins have also been
described. N1IC was shown to interact with and inhibit the actions
of JNK-interacting protein 1 (JIP1) in a variety of cell types (51).
This interaction required gamma-secretase-mediated cleavage and
physical association with the scaffold protein, JIP1, to negatively
regulate JNK-mediated apoptosis, following glucose deprivation
(51). Additionally, via its ANK 2 and 3 domains, N1IC can inter-
act with non-phosphorylated apoptosis signal-regulating kinase 1
(ASK1) in the cytosol, as well as with the phosphorylated form of
ASK1 in the nucleus (52). This association in MCF7 cells is thought
to provide protection from apoptosis under conditions of oxida-
tive stress (52). Thus, there may well-exist more global functions
of cytosolic NOTCH1 than has been appreciated to date.
The findings presented here, that cytosolic N1IC can directly
bind to CARMA1 and is required for further recruitment of
BCL10 and assembly of proteins required for IKK activation, and
IκBα phosphorylation strongly support a cytoplasmic function
of NOTCH1 in the first few hours following TCR engagement.
Together, these studies reveal the potential for a complementary
and reinforcing signaling cascade in stimulated T cells, one in
which N1IC acts in the cytoplasm as a molecular scaffold early on
to initiate NF-κB activation and, at later time points, in the nucleus
to facilitate NF-κB-mediated gene transcription.
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